C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/37 (2006.01) A01K 67/027 (2006.01) A61K 38/29 (2006.01) A61K 38/55 (2006.01) C07K 14/635 (2006.01) C12N 9/64 (2006.01) C12N 15/85 (2006.01) C12Q 1/00 (2006.01) G01N 33/68 (2006.01) G01N 33/74 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2245903
The present invention relates to a method for the diagnosis of metabolic bone diseases in a patient, which comprises the step of determining the level of PTHrP in a biological sample of a patient wherein an alteration of PTHrP levels from that of a normal individual is indicative of metabolic bone diseases and/or metabolic bone diseases predisposition. The present invention also relates to a method for the diagnosis of metabolic bone diseases in a patient, which comprises the step of determining the level of PTHrP in a biological sample of a patient wherein an alteration of PTHrP levels from that of a normal individual is indicative of metabolic bone diseases and/or metabolic bone diseases predisposition.
Goltzman David
Henderson Janet E.
Karaplis Andrew C.
Lipman Mark L.
Goltzman David
Henderson Janet E.
Karaplis Andrew C.
Lipman Mark L.
Swabey Ogilvy Renault
LandOfFree
Use of pex in the treatment of metabolic bone diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of pex in the treatment of metabolic bone diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pex in the treatment of metabolic bone diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2076096